Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xue CAI
Observed name:
Xue Cai
Institutions:
Hubei University of Medicine,
China National Pharmaceutical Group Corporation (China),
Dongfeng General Hospital
Observed institutions:
Hubei University of Medicine,
China National Pharmaceutical Group Corporation (China),
Dongfeng General Hospital
ORCID:
0009-0009-4980-4812
Observed ORCID:
0009-0009-4980-4812
OpenAlex ID:
A5128371468
Comparison of lesion detection rates between FAPI PET/CT and 18F-FDG PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis of head-to-head studies
2026
·
Qin Wang
, Xue Cai
, et al.
·
Japanese Journal of Radiology
Complementary roles of 68Ga-FAPI and 18 F-FDG PET/CT in evaluating IgG4-related disease: a systematic review and pooled analysis
2026
·
Xue Cai
, Qin Wang
, et al.
·
EJNMMI Research
Analysis and Outlook on the Use of 99m Tc-FAPI SPECT/CT in the Diagnosis of Primary and Metastatic Lesions of Cholangiocarcinoma
2026
·
Xue Cai
, Qingfan Hao
·
Cancer Biotherapy and Radiopharmaceuticals
Show more works
View as search
Works count:
3
Citation count:
H-index:
I10-index:
Year
Topic
Type